(Q31879027)

4 July 2017

title

Case fatality after an acute cardiac event: the effect of smoking and alcohol consumption (English)

1 reference

4 July 2017

0 references

2

Dobson AJ

1 reference

4 July 2017

McElduff P

1

1 reference

4 July 2017

publication date

1 January 2001

1 reference

Journal of Clinical Epidemiology

4 July 2017

published in

1 reference

4 July 2017

volume

54

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

58-67

1 reference

Factors determining case fatality in myocardial infarction "who dies in a heart attack"?

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Comparison of case fatality in smokers and non-smokers after acute cardiac event

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Smoking after acute myocardial infarction. A good thing?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Lifting the smoke-screen: the enigma of better outcome in smokers after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

Effect of moderate dose of alcohol with evening meal on fibrinolytic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900265-1

7 January 2021

10.1016/S0895-4356(00)00265-1

Identifiers

DOI

1 reference

4 July 2017

1 reference